Table II.

Association of Holliday junction recognition protein mRNA expression with clinicopathological characteristics in the Taylor dataset.

		HJURP
Clinical features	Cases, n	Mean ± SD	P-value
Tissues			<0.001
Benign	29	7.10±0.130
Cancer	150	7.31±0.245
Age, years			0.805
<60	93	7.31±0.261
≥60	57	7.30±0.219
Serum prostate-specific antigen, ng/ml			0.004
<10	105	7.25±0.201
≥10	42	7.40±0.279
Gleason score			0.005
<8	117	7.25±0.184
≥8	22	7.44±0.288
Clinical stage			0.731
<T2a	80	7.29±0.199
≥T2a	65	7.30±0.287
Pathological stage			0.007
T2a-T2c	86	7.24±0.162
T3a-T4	55	7.35±0.266
Metastasis			<0.001
No	122	7.24±0.165
Yes	28	7.60±0.311
Prostate-specific antigen failure			<0.001
Negative	104	7.23±0.168
Positive	36	7.42±0.260

HJURP, Holliday junction recognition protein.